Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer by Jing Liu, Chunyan Lan, Tongyu Liu, Qin Liu, Lele Chang, Lele Zang, Fei Zhu, Mingxuan Zhu, Huiqi Zhang, Yaxin Kang, Yuqin Wang, Huaiwu Lu, Yang Sun, Qin Xu

Subjects: “…Sintilimab…”
Get full text

Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab by Chang-Fu Liu, Xiao-Hui Zhao, Shi-Bo Zhu, Hai-Peng Yu, Wen-Ge Xing, Hui-Kai Li

Subjects: Get full text

Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma by Mi Meng, Bo Yu, Jie Luo, Yuju Bai, Lin Li, Shicheng Chen, Sisi He, Hu Ma

Subjects: “…sintilimab…”
Get full text

Development of a lung immune prognostic index-based nomogram model for predicting overall survival and immune-related adverse events in non-small cell lung cancer patients treated... by Jian Xu, Tingting Peng, Kaikai Fan, Yuxiao Dou, Lingti Kong, Ran Sang

Subjects: Get full text

Severe immune-mediated myocarditis caused by sintilimab combined with gemcitabine: a case report and literature review by Haixia Yang, Menglu Sun, Xiaosha Zhou, Yaxuan Han, Shanshan Zhang, Kelin Zhang, Xiaoyan Zhang

Subjects: Get full text

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma by Longjiang She, Longjiang She, Siqi Tang, Siqi Tang, Jiaqi Han, Jiaqi Han, Guichao Liu, Guichao Liu, Lusi Chen, Lusi Chen, Yang Zhang, Yang Zhang, Weijun Luo, Weijun Luo, Weihan Zuo, Weihan Zuo, Feng Ma, Feng Ma, Yan Xiong, Yan Xiong, Ning Zhang, Ning Zhang

Subjects: “…sintilimab…”
Get full text

Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports by Liwen Wang, Hua Ke, Chengdi Wang, Ke Wang

Subjects: Get full text

Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐A... by Xiaoyi Feng, Xiaoyan Liu, Hui Guan, Chunhong Chen, Feng Gao, Xiaoxing Gao, Minjiang Chen, Jing Zhao, Yan Xu, Mengzhao Wang

Subjects: Get full text

Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer by Peipei Mou, Fanghua Li, Yingying Wang, Feifei Zhao

Subjects: Get full text

Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review by Zhiqing Bai, Yu-Ann Chen, Ying Xiao, Jianping Song, Jianwei Song, Canhong Xiang

Subjects: Get full text

[Comment] Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial by Zhang Nan

Subjects: Get full text

Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review by Jing Zhang, Wenji Xiong, Hong Wang, Lemeng Sun, Chen Chen, Xueru Sun, Xiuyue Man, Lei Yang, Zhihong Li

Subjects: Get full text

Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial by Tianqing Chu, Hua Zhong, Zhuang Yu, Jing Wang, Yanqiu Zhao, Xiaoqian Mu, Xinmin Yu, Xun Shi, Qingming Shi, Maojing Guan, Cuimin Ding, Nan Geng, Jialin Qian, Baohui Han

Subjects: Get full text

Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer by Lin Jia, Naifei Chen, Xiao Chen, Chao Niu, Ziling Liu, Kewei Ma, Lei Yang, Yuguang Zhao, Wei Song, Jin Lu, Chen Chen, Xiaofeng Cong, Xu Wang, Yinghui Xu, Guozhen Cui, Zengguang Liu, Rongrong Chen, Huan Yin, Na Zhang, Jiuwei Cui

Subjects: Get full text

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report by Chenxi Zhang, Xiaoying Zhang, Jiali Liang, Yifei Liu, Jialong Chen, Qi Wang, Changxing Li, Changxing Li

Subjects: “…sintilimab…”
Get full text

Sintilimab-induced intestinal obstruction and hemorrhage of the digestive tract: a case report by Qian Hao, Wenwen Zhu, Qingqing Guo, Xiuxiu Lu, Shijun Zhang, Jianjun Yang, Zhonghua Song

Subjects: “…sintilimab…”
Get full text

Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspec... by Cuicui Yu, Yingqi Wu, Yadi Geng, Hui Yan, Pengli Zhu, Peng Ji, Fei Wu, Lijuan Ning, Yubin Feng, Aizong Shen

Subjects: Get full text

Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial by Xiaoyang Hong, Yongjian Guo, Wenbo Shi, Kangshun Zhu, Licong Liang, Liteng Lin, Ye Chen, Jingwen Zhou, Jingjun Huang, Jiabai Huang, Yaozhu Wu, Wensou Huang, Mingyue Cai

Subjects: Get full text

Short-term efficacy and safety of sintilimab combined with oxaliplatin and capecitabine as neoadjuvant therapy for locally advanced gastric cancer by ZHANG Shuai, LIU Liangliang, HUANG Di, SHENG Ru, DU Xuetao, LI Shuguang, HU Nan, ZHAO Yifeng

Subjects: Get full text

Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for HER2-negative advanced gastric cancer by ZHANG Xiaorui, SHAN Haixia, ZHU Zhengqiu

Subjects: Get full text